The ratio of breast to ovarian cancers is 2.39 : 1 for BRCA1 families and 6.18 : 1 for BRCA2 families, a difference which is significant at the 0.01% level by χ2 analysis. This evidence concerns the gene BRCA2 and ovarian carcinoma.